EVEREST MED-B(01952) appoints Ernst & Young as the new auditor.

Everest Med-B (01952) announces that, as the company was unable to reach an agreement with PricewaterhouseCoopers on the auditors' remuneration for the fiscal year ending on December 31, 2024, the Board of Directors has decided to replace PricewaterhouseCoopers as the auditors in order to enhance the cost-effectiveness of the annual audit and maintain good corporate governance. PricewaterhouseCoopers has agreed to resign as the company's auditors, effective from November 15, 2024. Upon recommendation from the Audit Committee, the Board has appointed Ernst & Young as the new auditors of the company, effective from November 15, 2024, to fill the interim vacancy left by PricewaterhouseCoopers and to serve until the end of the company's next Annual General Meeting.